Trial intelligence / Profile preview

Erythropoietin for ovarian protection after ovarian torsion reperfusion

IRCT201011305283N1Phase 4Completed

Sponsor
Tabriz University of Medical Sciences
Start
Nov 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of erythropoietin in ovarian torsion (OT), sponsored by Tabriz University of Medical Sciences. Started Nov 2009; status: completed.

02

Drugs

erythropoietin
03

Conditions

ovarian torsion (OT)

Beyond the preview

Go deeper on IRCT201011305283N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201011305283N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call